We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$6.45B
AUM Growth
+$725M
Cap. Flow
-$581M
Cap. Flow %
-9%
Top 10 Hldgs %
18%
Holding
1,317
New
227
Increased
165
Reduced
129
Closed
313

Sector Composition

Rank Sector Weight
1 Financials 13.98%
2 Technology 9.11%
3 Energy 6.09%
4 Healthcare 4.57%
5 Utilities 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVACW
851
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$130K ﹤0.01%
12,500
SLAMW
852
DELISTED
Slam Corp. warrant
SLAMW
$129K ﹤0.01%
12,500
DAKT icon
853
Daktronics
DAKT
$953M
$128K ﹤0.01%
+22,590
New +$92.2K
URGN icon
854
UroGen Pharma
URGN
$1.99B
$127K ﹤0.01%
+13,746
New +$126K
LMDX
855
DELISTED
LumiraDx Limited Common Shares
LMDX
$127K ﹤0.01%
273,034
+28,002
+11% +$26.8K
LCTX icon
856
Lineage Cell Therapeutics
LCTX
$267M
$125K ﹤0.01%
+83,395
New +$116K
PLUG icon
857
Plug Power
PLUG
$2.73B
$124K ﹤0.01%
10,558
KVHI icon
858
KVH Industries
KVHI
$172M
$123K ﹤0.01%
+10,786
New +$110K
CS
859
DELISTED
Credit Suisse Group
CS
$120K ﹤0.01%
+134,500
New +$375K
SMXWW
860
SMX (Security Matters) Public Ltd Warrant
SMXWW
$769K
$118K ﹤0.01%
+125,000
New +$10.2K
PSTX
861
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$117K ﹤0.01%
37,924
+14,396
+61% +$86.3K
HNRG icon
862
Hallador Energy
HNRG
$689M
$117K ﹤0.01%
12,680
+2,440
+24% +$20.6K
SCPH
863
DELISTED
scPharmaceuticals
SCPH
$115K ﹤0.01%
+12,726
New +$93.2K
PDLB icon
864
Ponce Financial Group
PDLB
$496M
$115K ﹤0.01%
14,692
-13,933
-49% -$126K
CLPT icon
865
ClearPoint Neuro
CLPT
$436M
$115K ﹤0.01%
+13,608
New +$119K
SMHI icon
866
SEACOR Marine Holdings
SMHI
$216M
$114K ﹤0.01%
+15,022
New +$143K
EPM icon
867
Evolution Petroleum
EPM
$131M
$113K ﹤0.01%
17,900
-6,382
-26% -$40.9K
SMMT icon
868
Summit Therapeutics
SMMT
$10B
$113K ﹤0.01%
+64,336
New +$175K
CABA icon
869
Cabaletta Bio
CABA
$445M
$111K ﹤0.01%
+13,422
New +$126K
SPOK icon
870
Spok Holdings
SPOK
$227M
$110K ﹤0.01%
+10,840
New +$99K
BSGAR
871
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$108K ﹤0.01%
200,000
WNEB icon
872
Western New England Bancorp
WNEB
$295M
$108K ﹤0.01%
+13,132
New +$124K
PDSB icon
873
PDS Biotechnology
PDSB
$38.6M
$108K ﹤0.01%
+17,520
New +$143K
SBIGW
874
DELISTED
SpringBig Holdings, Inc. Warrant
SBIGW
$106K ﹤0.01%
157,934
UPH
875
DELISTED
UpHealth, Inc.
UPH
$104K ﹤0.01%
70,000

Similar funds

LMR Partners's Q1 2023 Portfolio in Review

As of Q1 2023, LMR Partners held 1,317 positions worth $6.45B, up 13% from $5.73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $581M in Q1 2023, closing 313 positions and reducing 129 holdings. Its most notable exit was Bank of New York Mellon, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Energy.

Against the trend, LMR Partners opened a new position in AstraZeneca worth $42.7M.

  • LMR Partners's largest Q1 2023 buy was AstraZeneca: 307,414 shares worth $42.7M.
  • LMR Partners added most to First Horizon in Q1 2023, an estimated $77.4M increase.
  • LMR Partners's biggest Q1 2023 reduction was TSMC, cutting an estimated $121M.
  • LMR Partners fully exited Bank of New York Mellon in Q1 2023, selling an estimated $60M.
  • LMR Partners's ten largest holdings make up 18% of its $6.45B portfolio in Q1 2023.
  • LMR Partners opened 227 new positions and closed 313 in Q1 2023.
  • LMR Partners's portfolio value rose 13% quarter-over-quarter to $6.45B.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.